TF and cancer: While both TF and PDPN are targets of epigenetic and genetic oncogenic regulation (6, 47, 60) they may act in concert with each other and with other mediators expressed by altered cancer cells, or by the “activated” tumour stroma, and at the systemic level due to paracrine influence (61), thus potentially adding to the disease complexity.